Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rodenburg

Showing results (11-20 of 214) with videos related to

Pageof 22
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1993
Transcriptional and post-transcriptional regulation of the human IGF-II gene expressionJ S Sussenbach, R J Rodenburg, W Scheper, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 26, 2017
[Serious complications during treatment with methotrexate: also in chronic low-dosage use]R J Rodenburg, M J H Wijnands, P L Rensma
Molecular Endocrinology (Baltimore, Md.)|April 1, 1995
Postnatal liver-specific expression of human insulin-like growth factor-II is highly stimulated by the transcriptional activators liver-enriched activating protein and CCAAT/enhancer binding protein-alphaR J Rodenburg, W Teertstra, P E Holthuizen, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1988
Immunohistochemical detection of the ras oncogene product p21 in advanced ovarian cancer. Lack of correlation with clinical outcomeC J Rodenburg, I A Koelma, M Nap, et al.
Gynecologic Oncology|February 1, 1988
DNA flow cytometry and morphometry as prognostic indicators in advanced ovarian cancer: a step forward in predicting the clinical outcomeC J Rodenburg, C J Cornelisse, J Hermans, et al.
Histopathology|March 1, 1987
The value of tumour marker CA 125 in surgical pathologyI A Koelma, M Nap, C J Rodenburg, et al.
FEBS Letters|September 23, 1996
The liver-specific promoter of the human insulin-like growth factor-II gene contains two negative regulatory elementsR J Rodenburg, J J Krijger, P E Holthuizen, et al.
Nucleic Acids Research|June 25, 1992
The liver-specific promoter of the human insulin-like growth factor II gene is activated by CCAAT/enhancer binding protein (C/EBP)M A van Dijk, R J Rodenburg, P Holthuizen, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 12, 1998
[Taxoids in ovarian and breast carcinoma: the role of the medical profession and the government]P H Slee, M R Eliel, J W Nortier, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[Psychiatric symptoms in refugees reported to the Psychiatric Center De Vonk]W C Kleijn, J E Hovens, J J Rodenburg, et al.
Pageof 22

Showing results (11-20 of 214) with videos related to

Sort By:
Pageof 22
Advances in Experimental Medicine and Biology|January 1, 1993
Transcriptional and post-transcriptional regulation of the human IGF-II gene expressionJ S Sussenbach, R J Rodenburg, W Scheper, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 26, 2017
[Serious complications during treatment with methotrexate: also in chronic low-dosage use]R J Rodenburg, M J H Wijnands, P L Rensma
Molecular Endocrinology (Baltimore, Md.)|April 1, 1995
Postnatal liver-specific expression of human insulin-like growth factor-II is highly stimulated by the transcriptional activators liver-enriched activating protein and CCAAT/enhancer binding protein-alphaR J Rodenburg, W Teertstra, P E Holthuizen, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1988
Immunohistochemical detection of the ras oncogene product p21 in advanced ovarian cancer. Lack of correlation with clinical outcomeC J Rodenburg, I A Koelma, M Nap, et al.
Gynecologic Oncology|February 1, 1988
DNA flow cytometry and morphometry as prognostic indicators in advanced ovarian cancer: a step forward in predicting the clinical outcomeC J Rodenburg, C J Cornelisse, J Hermans, et al.
Histopathology|March 1, 1987
The value of tumour marker CA 125 in surgical pathologyI A Koelma, M Nap, C J Rodenburg, et al.
FEBS Letters|September 23, 1996
The liver-specific promoter of the human insulin-like growth factor-II gene contains two negative regulatory elementsR J Rodenburg, J J Krijger, P E Holthuizen, et al.
Nucleic Acids Research|June 25, 1992
The liver-specific promoter of the human insulin-like growth factor II gene is activated by CCAAT/enhancer binding protein (C/EBP)M A van Dijk, R J Rodenburg, P Holthuizen, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 12, 1998
[Taxoids in ovarian and breast carcinoma: the role of the medical profession and the government]P H Slee, M R Eliel, J W Nortier, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[Psychiatric symptoms in refugees reported to the Psychiatric Center De Vonk]W C Kleijn, J E Hovens, J J Rodenburg, et al.
Pageof 22